Wiesel’s wisdom a morality model for healthcare
For an industry hungry for ethical role models who transcend our fragmented healthcare system, a new book brings Elie Wiesel’s legacy into focus.
For an industry hungry for ethical role models who transcend our fragmented healthcare system, a new book brings Elie Wiesel’s legacy into focus.
He knew from his fractured childhood that courage in the face of adversity translated into survival and that empathy must be embedded in care and cures.
By now, you’ve probably heard about FTC efforts to ban reverse-payment patent settlements. FTC chairman Jon Leibowitz claims pharma-generic company deals are among “the most corrupt practices in healthcare today,” asserting settlements prevent cheaper generic drugs from entering the market sooner, delaying savings to consumers.
Just as it followed other sectors into CRM, the pharma industry must find entry points into the online patient conversation. Gil Bashe explores some of the issues, hurdles and opportunities of Web 2.0
Treating rare disorders was once considered a “good-will science endeavor,” but market forces have encouraged companies to revisit how these small molecules can be big business, and researchers are finding that therapeutic applications for one rare disease area often holds promise in others.